Target intelligence / Profile preview

Ubiquitin specific peptidase 34 (USP34)

Target
USP34
Molecular classification
Enzyme, Deubiquitinating enzyme, Cysteine protease
01

Overview

Ubiquitin specific peptidase 34 (USP34) is a large cysteine protease within the deubiquitinating enzyme family, characterized by its ability to cleave ubiquitin from protein substrates. It is implicated in multiple cellular processes, including regulation of the canonical Wnt signaling pathway by deubiquitinating and stabilizing AXIN1 and AXIN2, modulation of DNA double-strand break repair through stabilization of RNF168 and histone ubiquitination, and regulation of GPCR signaling by affecting the mRNA expression and cell surface abundance of receptors such as PAR1. USP34 is predominantly localized in the cytosol and nucleus, and its dysfunction has been associated with cancer, neurodevelopmental disorders, and altered osteogenesis. No clinically approved drugs are known to directly target USP34 as of the most recent literature.

Other names
Ubiquitin carboxyl-terminal hydrolase 34KIAA0570KIAA0729Deubiquitinating enzyme 34Ubiquitin thioesterase 34Ubiquitin-specific-processing protease 34ubiquitin specific protease 34
02

Mechanism of action

Inhibitors of USP34 would block its deubiquitinating activity, potentially destabilizing or degrading target proteins such as AXIN1/2. Modulation of the DNA damage response through interference with histone or protein ubiquitination.

03

Biological functions

Deubiquitination (removal of ubiquitin from target proteins)Regulation of Wnt signaling pathwayRegulation of protein stability and turnoverRegulation of DNA damage response and repairRegulation of G protein-coupled receptor (GPCR) signaling
04

Disease associations

Cancer (tumor progression and therapeutic resistance)Neurodegenerative diseaseOsteogenesis/bone diseaseAutism spectrum disorder
05

Safety considerations

Potential effects on DNA repair and genome stability if USP34 function is inhibited, raising risks for genomic instability or toxicityDisruption of normal cellular signaling pathways, including Wnt and GPCR regulation, could result in off-target effects or normal tissue dysfunction
06

Biomarkers

Altered USP34 expression or mutation status may serve as a biomarker for DNA damage response capacity, tumor progression, or prognosis in select cancers

Beyond the preview

Go deeper on Ubiquitin specific peptidase 34 (USP34).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 34 (USP34).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call